{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:06:17Z","timestamp":1777298777459,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC2411403"],"award-info":[{"award-number":["2023YFC2411403"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072085"],"award-info":[{"award-number":["82072085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["No. ZJ2021-ZD-007"],"award-info":[{"award-number":["No. ZJ2021-ZD-007"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-024-03884-2","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T12:36:56Z","timestamp":1731501416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy"],"prefix":"10.1007","volume":"74","author":[{"given":"Shicheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa X.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"3884_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fimmu.2020.00176","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Cao YJ (2020) Adoptive cell therapy targeting neoantigens: a frontier for cancer research. Front Immunol 11:176","journal-title":"Front Immunol"},{"issue":"7","key":"3884_CR2","doi-asserted-by":"publisher","first-page":"e002723","DOI":"10.1136\/jitc-2021-002723","volume":"9","author":"K Kirtane","year":"2021","unstructured":"Kirtane K, Elmariah H, Chung CH, Abate-Daga D (2021) Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead. J Immunother Cancer 9(7):e002723","journal-title":"J Immunother Cancer"},{"key":"3884_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","volume":"68","author":"K Newick","year":"2017","unstructured":"Newick K, O\u2019Brien S, Moon E, Albelda SM (2017) CAR T cell therapy for solid tumors. Annu Rev Med 68:139\u2013152","journal-title":"Annu Rev Med"},{"issue":"7","key":"3884_CR4","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin H, Meng Y, Peterson AC, Zha YY, Tretiakova M, Slingluff C et al (2009) Chemokine expression in melanoma metastases associated with CD8(+) T-cell recruitment. Can Res 69(7):3077\u20133085","journal-title":"Can Res"},{"issue":"1","key":"3884_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","volume":"17","author":"K Nakamura","year":"2020","unstructured":"Nakamura K, Smyth MJ (2020) Myeloid immunosuppression and immune checkpoints in the tumor microenvironment. Cell Mol Immunol 17(1):1\u201312","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"3884_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH (2021) Systemic immunity in cancer. Nat Rev Cancer 21(6):345\u2013359","journal-title":"Nat Rev Cancer"},{"key":"3884_CR7","first-page":"5703","volume":"2012","author":"Y Xie","year":"2012","unstructured":"Xie Y, Liu P, Xu LX (2012) A novel thermal treatment modality for controlling breast tumor growth and progression. Annu Int Conf IEEE Eng Med Biol Soc 2012:5703\u20135706","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"3","key":"3884_CR8","doi-asserted-by":"publisher","first-page":"e2703","DOI":"10.1038\/cddis.2017.125","volume":"8","author":"K He","year":"2017","unstructured":"He K, Liu P, Xu LX (2017) The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4(+) T-cell-mediated antitumor memory immune response. Cell Death Dis 8(3):e2703","journal-title":"Cell Death Dis"},{"key":"3884_CR9","doi-asserted-by":"publisher","first-page":"944115","DOI":"10.3389\/fimmu.2022.944115","volume":"13","author":"P Peng","year":"2022","unstructured":"Peng P, Lou Y, Wang JJ, Wang SC, Liu P, Xu LX (2022) Th1-dominant CD4(+) T cells orchestrate endogenous systematic antitumor immune memory after cryo-thermal therapy. Front Immunol 13:944115","journal-title":"Front Immunol"},{"issue":"6","key":"3884_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.7150\/thno.14394","volume":"6","author":"T Xue","year":"2016","unstructured":"Xue T, Liu P, Zhou Y, Liu K, Yang L, Moritz RL et al (2016) Interleukin-6 induced \u201cacute\u201d phenotypic microenvironment promotes Th1 anti-tumor immunity in cryo-thermal therapy revealed by shotgun and parallel reaction monitoring proteomics. Theranostics 6(6):773\u2013794","journal-title":"Theranostics"},{"issue":"3","key":"3884_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/02656736.2017.1332394","volume":"34","author":"K Liu","year":"2018","unstructured":"Liu K, He K, Xue T, Liu P, Xu LX (2018) The cryo-thermal therapy-induced IL-6-rich acute pro-inflammatory response promoted DCs phenotypic maturation as the prerequisite to CD4(+) T cell differentiation. Int J Hyperth 34(3):261\u2013272","journal-title":"Int J Hyperth"},{"key":"3884_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41419-019-1459-7","volume":"10","author":"K He","year":"2019","unstructured":"He K, Jia SG, Lou Y, Liu P, Xu LX (2019) Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity. Cell Death Disease 10:216","journal-title":"Cell Death Disease"},{"issue":"2","key":"3884_CR13","doi-asserted-by":"publisher","first-page":"e000421","DOI":"10.1136\/jitc-2019-000421","volume":"8","author":"P Peng","year":"2020","unstructured":"Peng P, Hu HM, Liu P, Xu LX (2020) Neoantigen-specific CD4(+)T-cell response is critical for the therapeutic efficacy of cryo-thermal therapy. J Immunother Cancer 8(2):e000421","journal-title":"J Immunother Cancer"},{"issue":"43","key":"3884_CR14","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"3884_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross SH, Cantrell DA (2018) Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol 36:411\u2013433","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3884_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1081-1206(10)62426-X","volume":"85","author":"S Romagnani","year":"2000","unstructured":"Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85(1):9\u201318","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"3884_CR17","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/cancers14071771","volume":"14","author":"A Aran","year":"2022","unstructured":"Aran A, Garrigos L, Curigliano G, Cortes J, Marti M (2022) Evaluation of the TCR repertoire as a predictive and prognostic biomarker in cancer: diversity or clonality? Cancers 14(7):1771","journal-title":"Cancers"},{"issue":"9","key":"3884_CR18","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/s41423-020-0449-0","volume":"18","author":"MX Yu","year":"2021","unstructured":"Yu MX, Pan H, Che N, Li L, Wang C, Wang Y et al (2021) Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells. Cell Mol Immunol 18(9):2153\u20132164","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"3884_CR19","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1158\/0008-5472.CAN-03-2646","volume":"64","author":"EA Danna","year":"2004","unstructured":"Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S (2004) Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res 64(6):2205\u20132211","journal-title":"Cancer Res"},{"issue":"1","key":"3884_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","volume":"22","author":"KM Maalej","year":"2023","unstructured":"Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C et al (2023) CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer 22(1):20","journal-title":"Mol Cancer"},{"issue":"18","key":"3884_CR21","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Can Res 79(18):4557\u20134566","journal-title":"Can Res"},{"issue":"1","key":"3884_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ymthe.2020.09.034","volume":"29","author":"R Sun","year":"2021","unstructured":"Sun R, Luo H, Su J, Di S, Zhou M, Shi B et al (2021) Olaparib suppresses MDSC recruitment via SDF1alpha\/CXCR4 axis to improve the anti-tumor efficacy of CAR-T cells on breast cancer in mice. Mol Ther 29(1):60\u201374","journal-title":"Mol Ther"},{"issue":"10","key":"3884_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1158\/2326-6066.CIR-15-0230","volume":"4","author":"AH Long","year":"2016","unstructured":"Long AH, Highfill SL, Cui Y, Smith JP, Walker AJ, Ramakrishna S et al (2016) Reduction of MDSCs with all-trans retinoic acid improves CAR therapy efficacy for sarcomas. Cancer Immunol Res 4(10):869\u2013880","journal-title":"Cancer Immunol Res"},{"key":"3884_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1746","author":"DG DeNardo","year":"2007","unstructured":"DeNardo DG, Coussens LM (2007) Inflammation and breast cancer\u2014balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res. https:\/\/doi.org\/10.1186\/bcr1746","journal-title":"Breast Cancer Res"},{"issue":"5","key":"3884_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger S, Dai D, Horton B, Gajewski TF (2017) Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell 31(5):711\u201323","journal-title":"Cancer Cell"},{"issue":"7776","key":"3884_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria O, Cornen S, Daeron M, Morel Y, Medzhitov R, Vivier E (2019) Harnessing innate immunity in cancer therapy. Nature 574(7776):45\u201356","journal-title":"Nature"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-024-03884-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-024-03884-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-024-03884-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T17:48:27Z","timestamp":1738259307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-024-03884-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["3884"],"URL":"https:\/\/doi.org\/10.1007\/s00262-024-03884-2","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by the Animal Welfare Committee of Shanghai Jiao Tong University, and experimental methods were performed in accordance with the guidelines of Shanghai Jiao Tong University Animal Care (approved by Shanghai Jiao Tong University Scientific Ethics Committee, Registration No. 2020017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"21"}}